Beligas Pharma, headquartered in Belgium, is a distinguished entity in the pharmaceutical and biotechnology industry. We collaborate with manufacturing sites in Belgium and Shanghai, China, specializing in the development and production of pharmacological substances aimed at enhancing the quality of life.
Our product portfolio encompasses over 130 drugs, a majority of which are classified as vital medicines. These medicines cater to various pharmacotherapeutic needs and are produced in strict compliance with Good Manufacturing Practice (GMP) standards.
Beligas Pharma’s product line includes medicines used in testosterone therapy, weight loss, and treatment of erectile dysfunction post-surgical rehabilitation, among others.
We are committed to the modernization and expansion of production technologies, continually developing new, including digital, technologies. This commitment has led to consistent growth in both the production and sales of our finished products.
Our primary focus is on generic products. Our team of professional pharmacists oversees the quality of the production process to deliver high-quality products to our customers. Each product undergoes clinical testing prior to market placement.
Beligas Pharma is dedicated to producing high-quality medicaments, available globally through our network of partners and distributors, at prices that reflect the purchasing ability of the average citizen.
